|
1883
|
NS 3694
|
Inhibitor of apoptosis; Inhibits formation of apoptosome complex |
€90.00 |
|
2094
|
NS 6180
|
KCa3.1 channel blocker |
€90.00 |
|
2955
|
NSC 228155
|
EGFR tyrosine kinase activator; Inhibitor of KIX-KID interaction |
€75.00 |
|
2695
|
NSC 23005 sodium
|
Novel small molecule inhibitor of INK4C (p18(INK4C) or p18) |
€90.00 |
|
1578
|
NSC 23766
|
Rac1 inhibitor |
€110.00 |
|
2016
|
NSC 319726
|
Reactivator of the p53 mutant p53R175 |
€95.00 |
|
1402
|
NSC 348884
|
NPM inhibitor |
€120.00 |
|
2162
|
NSC 405020
|
MT1-MMP inhibitor specifically targeting PEX-domain. |
€85.00 |
|
1332
|
NSC 45913
|
Building Block; unknown pharmacology |
Inquire |
|
2564
|
NSC 59984
|
Activator of p53 that restores WT p53 signaling via p73 activation |
€95.00 |
|
1243
|
NSC 625987
|
CDK4 inhibitor |
€95.00 |
|
2228
|
NSC 687852
|
Inhibitor of 19S regulatory-particle–associated deubiquitinases (DUBs: UCHL5 and USP14) |
€90.00 |
|
2393
|
NSC 756093
|
Potent in vitro inhibitor of GBP1:PIM1 interaction |
€125.00 |
|
3086
|
NSC 95397
|
Potent and selective Cdc25 dual specificity phosphatase (DUSP) inhibitor |
€70.00 |
|
3277
|
NSC194598
|
p53 DNA-binding inhibitor |
€130.00 |
|
2966
|
NSC745887
|
DcR3 inhibitor |
€95.00 |
|
2238
|
NT 157
|
Unique allosteric inhibitor of IGF1R signaling |
€95.00 |
|
1370
|
NU 1025
|
PARP inhibitor |
€80.00 |
|
1463
|
NU 7441
|
DNA-PK inhibitor |
€40.00 |
|
2907
|
Nucleozin
|
Influenza A nucleoprotein targeting molecule |
€95.00 |
|
1585
|
Nutlin-3
|
MDM2 inhibitor (p53 specific) |
€95.00 |
|
1880
|
Nutlin-3a
|
Inhibitor of MDM2 |
€95.00 |
|
1881
|
Nutlin-3b
|
Less potent (+)-enantiomer of Nutlin-3 |
€90.00 |
|
1600
|
NVP 231
|
CerK inhibitor |
€85.00 |
|
2865
|
NVP-ACC789
|
Inhibitor of VEGFR2 |
€90.00 |
|
1542
|
NVP-AUY922
|
Hsp90 inhibitor |
€75.00 |
|
1520
|
NVP-BBD130
|
Dual PI3K and mTOR kinase inhibitor |
€125.00 |
|
1775
|
NVP-BGJ398
|
Inhibitor of FGFR tyrosine kinases 1, 2 ,3 and 4 |
€80.00 |
|
1944
|
NVP-BGJ398 phosphate
|
Inhibitor of FGFR tyrosine kinases 1, 2 ,3 and 4 |
€90.00 |
|
2029
|
NVP-BGT226
|
Orally active dual PI3K/mTOR inhibitor |
€120.00 |